An estimate of prostate cancer prevalence for a demographically similar workforce population
Westra, C.S.; Ducatman, A.M.; Niewiadomska-Bugaj, M.; Hobbs, G.R.
West Virginia Medical Journal 95(3): 116-122
1999
ISSN/ISBN: 0043-3284 PMID: 10352568 Document Number: 503782
Document emailed within 1 workday
Related Documents
Liu, J-he.; Li, H-wei.; Tong, M.; Li, M.; Na, Y-qun. 2004: Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer Zhonghua Yi Xue Za Zhi 84(5): 364-368Mitra, S.; Das Gupta, A. 1960: An estimate of the prevalence of cancer in India Bulletin of the World Health Organization 22: 485-492
Palli, D.; Masala, G.; Trallori, G.; Bardazzi, G.; Saieva, C. 1998: A capture-recapture estimate of inflammatory bowel disease prevalence: the Florence population-based study Italian Journal of Gastroenterology and Hepatology 30(1): 50-53
Srinualnad, S.; Charoenkraikamol, C.; Toraksa, S.; Uiprasertkul, M.; Amornvesukit, T.; Taweemonkongsap, T.; Udompunturak, S.; Nualyong, C.; Tantiwong, A. 2006: Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day) Journal of the Medical Association of Thailand 89(1): 37-42
Evans, W.K. 1997: Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module Seminars in Oncology 24(2 Suppl 7: S7
Zhu, X-Dong.; Zheng, A.; Wang, Z-Qian.; Shao, Q. 2018: Prostate Cancer Prevention Trial risk calculator for evaluating the risk of prostate cancer in the high-risk Chinese population Zhonghua Nan Ke Xue 24(2): 142-146
Biadgilign, S.; Lakew, Y.; Reda, A.A.; Deribe, K. 2013: A population based survey in Ethiopia using questionnaire as proxy to estimate obstetric fistula prevalence: results from demographic and health survey Reproductive Health 10: 14
Biadgilign, S.; Lakew, Y.; Reda, A.A.; Deribe, K. 2013: A population based survey in Ethiopia using questionnaire as proxy to estimate obstetric fistula prevalence: results from demographic and health survey Reproductive Health 10: 14
McKenzie, J. 2000: Information needs of patients with cancer. Similar study had similar findings Bmj 321(7261): 632; Author Reply 633
Sathitkarnmanee, E.; Sirithanaphol, W.; Chotikawanich, E. 2012: Prevalence of prostate cancer in northeastern Thailand Journal of the Medical Association of Thailand 95(Suppl 11): S38-S41
Tantiwong, A.; Soontrapa, S.; Sujijantrarat, P.; Vanprapar, N.; Sawangsak, L. 2002: The prevalence of prostate cancer screening in Thai elderly Journal of the Medical Association of Thailand 85(4): 502-508
Debouzie, D. 1980: Estimate of variance effective population size in a laboratory ceratitis capitata population Heredity 45(2): 297-300
Dahmani, L.; Wagner, B.; Auzanneau, C.; Irani, J.; Doré, B. 2003: Prevalence of osteoporotic fractures in patients treated by androgen blockade for prostate cancer Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 13(1): 73-78
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Suzuki, K.; Ohtake, N.; Nakata, S.; Takei, T.; Matsui, H.; Ono, Y.; Nakazato, H.; Hasumi, M.; Koike, H.; Ito, K.; Fukabori, Y.; Kurokawa, K.; Yamanaka, H. 2002: Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population Anticancer Research 22(6b): 3507-3511
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Adewumi, A.O.; Anthonia, S.C.; Alabi, A.S.; Amina, F.O.; Kingsley, K.K. 2016: Pattern of prostate cancer among a Nigerian population: a study in a single tertiary care centre Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria 25(1): 70-76